市場調查報告書
商品編碼
1470940
傷口縫合和進階創傷護理市場:按產品、應用和最終用戶分類 - 2024-2030 年全球預測Wound Closure & Advanced Wound Care Market by Product (Collagen-Based Sealants, Fibrin-Based Sealants, Hydrocolloids-Based Sealants), Application (Acute Wounds, Chronic Wounds), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
傷口縫合和高級創傷護理市場規模預計到 2023 年為 163.4 億美元,預計到 2024 年將達到 178.6 億美元,到 2030 年將達到 307.8 億美元,複合年成長率為 9.47%。
傷口縫合是一種醫療程序,旨在使傷口邊緣接近,以促進癒合最大程度地降低感染風險。這個過程對於受傷或手術後恢復皮膚完整性和功能至關重要。傷口縫合技術根據傷口的性質和嚴重程度而有所不同,可能包括縫合、釘書釘、膠帶或黏劑。此外,醫療保健投資的增加以及對縮短住院時間的關注也對市場成長做出了積極貢獻。然而,與傷口護理和管理相關的高成本以及與慢性傷口護理相關的複雜問題可能會對市場成長帶來挑戰。然而,引入結合感測器和資料分析來監測創傷治療和減少併發症的智慧創傷護理解決方案預計將為市場帶來重大商機。此外,組織工程和幹細胞治療的進步為市場提供了重大機會。
主要市場統計 | |
---|---|
基準年[2023] | 163.4億美元 |
預測年份 [2024] | 178.6億美元 |
預測年份 [2030] | 307.8億美元 |
複合年成長率(%) | 9.47% |
產品 支持組織癒合的膠原蛋白封閉劑的普及
膠原蛋白密封劑源自動物膠原蛋白,用於促進止血(止血)和支持組織癒合。它適用於各種手術和外傷傷口,以幫助凝固並作為新組織生長的支架。膠原蛋白密封劑因其天然的止血特性和優異的生物相容性而成為涉及重要器官的手術和易出血患者的首選。以纖維蛋白為基礎的密封劑模仿體內凝血連鎖的最後階段,形成纖維蛋白凝塊以止血。它們由濃縮的人類纖維蛋白原和凝血酶開發而成,可與機械閉合技術結合使用。以纖維蛋白為基礎的密封劑有效地模仿人體的自然凝血過程並且完全可吸收,這就是為什麼它們被用來治療患有凝血障礙或接受複雜外科手術的患者。親水膠體是吸收性黏性物質,當它們與傷口滲出物接觸時形成凝膠。親水膠體有助於維持濕潤的傷口環境,有助於創傷治療,也可用於壓瘡、燒傷和複雜傷口。這些密封劑可用於多種傷口類型,特別有利於處理輕度至中度滲出的傷口。合成黏劑是非生物化合物,可以快速黏合組織表面以閉合傷口。它們通常由氰基丙烯酸酯組成,是快速聚合劑,可提供即時的傷口縫合強度。合成黏劑通常用於閉合小割傷、撕裂傷和切口,主要是在需要快速、即時閉合傷口時。
應用 糖尿病足潰瘍等慢性傷口的傷口縫合與進階創傷護理偏好
慢性傷口,如腿部靜脈性潰瘍、褥瘡和糖尿病足潰瘍,是指在預期時間內無法癒合的傷口。這些傷口通常與糖尿病或循環系統疾病等潛在疾病有關,其持續性使得處理起來相當昂貴。治療方法包括先進的敷料、傷口護理設備、生物合成和生物皮膚替代,旨在解決根本原因並促進癒合。糖尿病足潰瘍(DFU)是糖尿病的主要併發症,對發病率和死亡率有重大影響。正確護理 DFU 對於預防可能導致截肢的感染疾病至關重要。壓力性潰瘍是由於皮膚長期受壓而造成的皮膚和皮下組織損傷。壓瘡通常發生在臥床或行動不便的患者身上。壓瘡治療包括專用床墊和墊子等減壓裝置,以及促進組織再生和防止感染的先進傷口敷料。腿部靜脈性潰瘍是由於血液循環不良,特別是靜脈功能不全而引起的小腿慢性潰瘍。治療主要包括改善血液循環的壓迫療法和適合傷口環境的敷料。
最終用戶:擴大被醫院採用,從外科手術到急診醫學。
該診所向門診病人開放,治療不需要住院的輕到中度傷口。診所通常偏好經濟高效、易於使用且患者周轉速度快的產品。常用的產品有可吸收縫線、黏合帶和局部皮膚黏劑等。此外,診所可能會使用先進的敷料來加速癒合並減少後續觀察的需要。在家庭醫療保健領域,需要易於患者和看護者獨立使用的產品。優選能夠保持濕潤的傷口環境並且可以留在原處而不需要頻繁更換的先進敷料。隨著傷口護理設備變得更加方便和攜帶,居家照護的需求也不斷增加。醫院需要各種傷口縫合和護理產品來治療各種傷口。首選產品可縮短患者復原時間,最大限度地降低感染風險,並可用於從手術到緊急護理的各種程序。常見的選擇包括U形釘、高級縫線、手術密封劑以及用於燒燙傷治療和手術傷口的高級敷料。
區域洞察
美洲的傷口縫合和先進創傷護理市場高度發達,擁有成熟的醫療基礎設施來支持研究、開發和分銷。美洲消費者的需求面向高品質、技術先進的產品,重點在於微創解決方案。美國擁有許多開創性的研究舉措,這些舉措通常得到公共和私營部門大規模投資的支持。市場也不斷努力透過開發術後護理的替代疼痛管理解決方案來解決鴉片類藥物危機。 EMEA(歐洲、中東和非洲)地區是一個多元化的市場,產品採用率和醫療保健支出水準各不相同。歐盟 (EU) 國家擁有標準化的法律規範,使其成為先進創傷護理產品的穩定市場。歐洲、中東和非洲地區的消費者需求差異很大,西歐更喜歡尖端產品,而非洲和中東則對價格更為敏感。歐洲、中東和非洲地區是尖端專利和研究的熱點,並且經常受益於歐盟的資助和「地平線歐洲」等舉措。亞太地區傷口縫合和先進傷口護理市場正在經歷顯著成長。這是由人口老化、慢性傷口發病率上升以及醫療基礎設施不斷擴大所推動的。由於自付費用高昂的醫療費用,該地區消費者的需求受到對具有成本效益的產品的需求的推動。最近的投資主要集中在提高產品可用性和擴大本地製造能力。
FPNV定位矩陣
FPNV定位矩陣對於評估傷口縫合和進階創傷護理市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對傷口縫合和高階創傷護理市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.傷口縫合和高級創傷護理市場的市場規模和預測是多少?
2.在傷口縫合和高級創傷護理市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.傷口縫合和先進創傷護理市場的技術趨勢和法規結構是什麼?
4.傷口縫合和高級創傷護理市場主要供應商的市場佔有率是多少?
5. 進入傷口縫合和先進創傷護理市場的適當型態和策略性手段是什麼?
[192 Pages Report] The Wound Closure & Advanced Wound Care Market size was estimated at USD 16.34 billion in 2023 and expected to reach USD 17.86 billion in 2024, at a CAGR 9.47% to reach USD 30.78 billion by 2030.
Wound closure is a medical procedure aimed at approximating the edges of a wound to facilitate healing and minimize the risk of infection. This process is crucial for restoring the skin's integrity and function following an injury or surgery. Wound closure techniques vary depending on the nature and severity of the wound and include sutures, staples, adhesive tapes, and adhesives. Moreover, enhanced investment in healthcare and focus on reducing hospital stays contribute positively to market growth. However, the high costs associated with wound care and management and the complexity issues associated with chronic wound treatments may challenge the market growth. Nevertheless, the introduction of smart wound care solutions incorporating sensors and data analytics to monitor wound healing and reduce complications is expected to offer significant opportunities for the market. Moreover, advances in tissue engineering and stem cell therapy offer significant opportunities within the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 16.34 billion |
Estimated Year [2024] | USD 17.86 billion |
Forecast Year [2030] | USD 30.78 billion |
CAGR (%) | 9.47% |
Product: Proliferation of collagen-based sealants to support tissue healing
Collagen-based sealants are derived from animal collagen and are used to promote hemostasis (the cessation of bleeding) and to support tissue healing. They can be applied to various surgical and traumatic wounds to assist in clotting and act as a scaffold for new tissue growth. Collagen-based sealants are preferred in surgeries involving vital organs and patients prone to bleeding because of their natural hemostatic properties and excellent biocompatibility. Fibrin-based sealants mimic the final stages of the body's coagulation cascade, forming a fibrin clot to stop bleeding. They are developed from concentrated human fibrinogen and thrombin and can be used in conjunction with mechanical closure techniques. Fibrin-based sealants are used to treat patients with clotting disorders or undergoing complex surgical procedures, as they effectively mimic the body's natural clotting process and are fully resorbable. Hydrocolloids are absorbent, adhesive substances that form a gel when in contact with wound exudate. They help maintain a moist wound environment, which is beneficial for healing and can be used for pressure ulcers, burns, and complex wounds. These sealants are often preferred for their ability to be used on various wound types and are particularly beneficial in managing small to moderate exuding wounds. Synthetic adhesives are non-biological compounds that quickly bond tissue surfaces to close wounds. They often consist of cyanoacrylates, rapidly polymerizing agents providing immediate wound closure strength. Synthetic adhesives are commonly used to close minor cuts, lacerations, or incisions, mainly when speed and immediate sealing of the wound is required.
Application: Preferences for wound closure & advanced wound care in chronic wounds such as diabetic foot ulcers
Chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, are wounds that fail to heal within the expected timeframe. These wounds are often associated with underlying health conditions, such as diabetes or circulatory problems, and can be considerably costly to manage due to their persistent nature. The treatment includes advanced dressings, negative pressure wound therapy devices, and biosynthetic and biological skin substitutes that aim to address the underlying causes and promote healing. Diabetic foot ulcers (DFUs) are a major complication of diabetes, with a significant impact on morbidity and mortality. Proper care of DFUs is critical in preventing infections that can lead to amputations. Pressure ulcers are injuries to the skin and underlying tissue resulting from prolonged pressure on the skin. They commonly occur in patients who are bedridden or immobile. Pressure ulcer treatment includes pressure-relieving devices such as specialized mattresses and cushions and advanced wound dressings that promote tissue regeneration and protect against infection. Venous leg ulcers are chronic sores that occur on the lower legs due to poor blood circulation, specifically venous insufficiency. The mainstay of treatment involves compression therapy to improve circulation, along with dressings that cater to the specific needs of the wound environment.
End-User: Increased adoption in hospital setting owing to procedures ranging from surgery to emergency care
Clinics cater to outpatients and handle minor to moderate wounds that do not require hospitalization. The preference in clinics is usually for cost-effective, easy-to-use products that allow for quick patient turnover. Products such as absorbable sutures, adhesive strips, and topical skin adhesives are commonly used. Additionally, clinics may utilize advanced dressings that promote faster healing and reduce the need for follow-up visits. The home healthcare segment requires products that are easy for patients or caregivers to use independently. Advanced dressings that maintain a moist wound environment and can be left in place without frequent changes are preferred. Negative pressure wound therapy devices are also seeing an increased demand for in-home care as technology becomes more accessible and portable. Hospitals require a broad spectrum of wound closure and care products to address the varied and often more complex wounds treated in this setting. The preferred products can reduce patient recovery time, minimize the risk of infection, and be used in procedures ranging from surgery to emergency care. Staples, advanced sutures, surgical sealants, and sophisticated dressings for burn care and surgical wounds are common choices.
Regional Insights
The wound closure and advanced wound care market in the Americas is highly developed, with well-established healthcare infrastructure supporting R&D and distribution. Consumer needs in the Americas are geared towards high-quality and technologically advanced products, focusing on minimally invasive solutions. The U.S. hosts several ground-breaking research initiatives, often backed by large investments from both private and public sectors. The market has also seen a wave of initiatives aiming to address the opioid crisis by developing alternative pain management solutions for post-surgical care. The EMEA region presents a diverse market with varying degrees of product adoption and healthcare spending. With their standardized regulatory framework, the European Union countries offer a stable market for advanced wound care products. Consumer needs across EMEA vary greatly, with Western Europe favoring cutting-edge products, while price sensitivity is more pronounced in Africa and the Middle East. The EMEA region is an active site for the latest patents and research, which often benefit from EU funding and initiatives such as Horizon Europe. The Asia Pacific region is witnessing significant growth in the wound closure and advanced wound care market. This can be attributed to an increasing aging population, a rising incidence of chronic wounds, and an expanding healthcare infrastructure. Consumer needs within the region are driven by a demand for cost-effective products due to high out-of-pocket healthcare spending. Recent investments are focused on improving product accessibility and expanding local production capabilities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Wound Closure & Advanced Wound Care Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Wound Closure & Advanced Wound Care Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Wound Closure & Advanced Wound Care Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Argentum Medical, Axio Biosolutions Private Limited by Advamedica Inc., B. Braun SE, Cardinal Health, Inc., Coloplast A/S, Convatec Limited, Essity AB, Hollister Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lohmann & Rauscher GmbH & Co. KG, Medline Industries, LP, Medtronic PLC, MIMEDX Group, Inc., Misonix, Inc. by Bioventus LLC, Molnlycke Health Care AB, Organogenesis Inc., Paul Hartmann AG, PolarityTE, Inc., Smith & Nephew PLC, Tides Medical, Tissue Regenix Ltd., Urgo Ltd., and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Wound Closure & Advanced Wound Care Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Wound Closure & Advanced Wound Care Market?
3. What are the technology trends and regulatory frameworks in the Wound Closure & Advanced Wound Care Market?
4. What is the market share of the leading vendors in the Wound Closure & Advanced Wound Care Market?
5. Which modes and strategic moves are suitable for entering the Wound Closure & Advanced Wound Care Market?